Novel insights through patient-centric, data-driven R&D
Unique sample resource
20+ years of pre-analytically controlled tumor and normal tissue samples, combined with comprehensive clinical and follow-up data
)
Comprehensive multi‑omics and clinical database
Highly standardized, proprietary multi‑omics and clinical data that reflects the molecular reality of cancer at an unparalleled level
:format(webp))
Cutting-edge biomathematical tools
A state-of-the-art combination of biomathematical and bioinformatic approaches, including specifically designed AI tools
:format(webp))
Patient-derived cellular models
Proprietary, well-characterized 2D and 3D tumor models that closely represent disease characteristics for reliable target validation
:format(webp))
:format(webp))
:format(webp))
Target discovery based on unique data
Based on comprehensive multi-omics and clinical data, our method exploits graph analytics and yields innovative target candidates.
:format(webp))
)
In-depth target validation
With cellular models derived from the original patient cohort, we go the extra mile in validation and characterization of selected targets.
:format(webp))
:format(webp))
Cancer drug discovery beyond target ID and validation
We progress small and large molecules along the drug discovery and development pipeline toward IND and beyond.
:format(webp))
)
Our rapidly growing pipeline
Our expanding CRC pipeline of therapeutically novel targets is a testament to how our unique approach leads to tangible results.
Partnering As a partner in R&D, we have a lot to offer.
Company news and publicationsStay up to date with our latest news and publications.
)
)
)
Careers Help us shape the future of precision oncology.
One way or another, we can all be touched by the impact of cancer. That is why, for many of us, working at Indivumed is so much more than just a job. We are united by our shared purpose and passion: to improve cancer treatment for patients around the world.